Open access dataset reveals how factors such as diet, antibiotics and mental health status can influence the microbial and molecular makeup of your gut.
Repositive, has successfully concluded the pilot phase of its data-sharing platform for PDX cancer models and is now extending the scope of the platform to include a wider range of translational cancer models.
Karius has developed a next-generation sequencing test for microbial cell-free DNA that provides clinicians with a comprehensive test capable of identifying more than 1,250 pathogens directly from blood.
Cofactor Genomics, the developer of advanced RNA analysis tools, has announced that it has entered into an agreement with the National Cancer Institute, to demonstrate the clinical utility of its immune-profiling assay, Cofactor Paragon.
ArcherDX, a company known for producing NGS-based gene fusion detection assays, has closed a $35 million Series A preferred financing,
Designed to accelerate pre-clinical genomic research and drug discovery for the benefit of patients, the team behind the global genomic data marketplace has grown by nearly 50% in the past year.
New research shows that a test for measuring the length of DNA endcaps called telomeres can alter treatment decisions for patients with certain types of bone marrow failures.
QIAGEN enters into agreement to acquire STAT-Dx, plans to launch a next-generation, fully integrated multiplex platform for syndromic disease testing in second half 2018 in Europe and later in the U.S.
SeraCare announces industry’s first CNV-specific reference material for gene amplifications in breast, lung, and brain cancer.
NHGRI launches a new strategic plan to identify areas in genomics that will expand the field into new frontiers and enable novel applications to human health and disease.
The GA4GH roadmap outlines the first set of standards and frameworks to be launched under GA4GH Connect—a new phase of the organization focused on aligning with the needs of the real-world genomic data sharing community.
SOPHiA GENETICS has unveiled the world’s first capture-based myeloid clinical solution to receive the CE-IVD mark. The standardized molecular diagnostic application represents a breakthrough in diagnostics for hematological diseases.
In the 18 months that the Wolfson Childhood Research Centre has been open, researchers have secured a further £5 million in grants to continue world-class childhood cancer research.
The Human Genome Project has been awarded the 2017 Prince Mahidol Award for ground-breaking advances in the field of medicine.
Illumina Ventures- and Merck-backed DNA Script have gotten one step closer to its vision of higher speed, higher efficiency, harsh-chemical free DNA synthesis.